benzamide and imatinib mesylate

benzamide has been researched along with imatinib mesylate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barcza, L; Béni, S; Csernák, O; Noszál, B; Szakács, Z	1
Ding, K; Leng, F; Li, Y; Long, H; Lu, X; Luo, J; Pan, X; Ren, X; Shen, M; Tu, Z; Wen, D; Zhang, F; Zhang, Z	1

Other Studies

2 other study(ies) available for benzamide and imatinib mesylate

Article	Year
Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2007, Volume: 30, Issue:2 Topics: Antineoplastic Agents; Benzamides; beta-Cyclodextrins; Binding Sites; Binding, Competitive; Drug Stability; Imatinib Mesylate; Magnetic Resonance Spectroscopy; Molecular Structure; Piperazines; Pyrimidines; Solubility; Spectrometry, Mass, Electrospray Ionization; Technology, Pharmaceutical	2007
Design, synthesis, and biological evaluation of 3-(1H-1,2,3-triazol-1-yl)benzamide derivatives as Potent Pan Bcr-Abl inhibitors including the threonine(315)→isoleucine(315) mutant. Journal of medicinal chemistry, 2012, Nov-26, Volume: 55, Issue:22 Topics: Benzamides; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Drug Design; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Isoleucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Models, Molecular; Molecular Structure; Mutation; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship; Threonine	2012

Article

Year

Cyclodextrin/imatinib complexation: binding mode and charge dependent stabilities.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2007, Volume: 30, Issue:2

Topics: Antineoplastic Agents; Benzamides; beta-Cyclodextrins; Binding Sites; Binding, Competitive; Drug Stability; Imatinib Mesylate; Magnetic Resonance Spectroscopy; Molecular Structure; Piperazines; Pyrimidines; Solubility; Spectrometry, Mass, Electrospray Ionization; Technology, Pharmaceutical

2007

Design, synthesis, and biological evaluation of 3-(1H-1,2,3-triazol-1-yl)benzamide derivatives as Potent Pan Bcr-Abl inhibitors including the threonine(315)→isoleucine(315) mutant.

Journal of medicinal chemistry, 2012, Nov-26, Volume: 55, Issue:22

Topics: Benzamides; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Drug Design; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Isoleucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Models, Molecular; Molecular Structure; Mutation; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship; Threonine

2012